Santen Pharmaceutical Co Financial Overview
Santen Pharmaceutical Co's market cap is currently ¥527.02B. The company's EPS TTM is ¥24.44; its P/E ratio is 17.76; and it has a dividend yield of 2.30%. Santen Pharmaceutical Co is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ¥27.89. See an overview of income statement, balance sheet, and cash flow financials.
